Form 4: Hologic Inc. Executive Benjamin Cohn Reports Stock Transaction

Hologic Inc.'s Principal Accounting Officer, Benjamin Cohn, disposed of 110 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• Benjamin Cohn, the Principal Accounting Officer at Hologic Inc., reported a transaction involving the company's common stock.
• On November 14, 2024, Mr. Cohn disposed of 110 shares of Hologic common stock.
• The shares were sold at a price of $77.54 per share.
• This transaction was to cover tax obligations related to the vesting of restricted stock units.
• Following the transaction, Mr. Cohn directly owns 11,250 shares of Hologic common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of an insider stock transaction, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation. It does not indicate any specific trend or issue within the company or the broader medical technology industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, such as Hologic, and are required by the SEC to ensure transparency of insider transactions.
• Similar filings are made by executives at comparable companies like Abbott Laboratories (ABT) and Medtronic (MDT) when they engage in stock transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale of shares by an executive for tax purposes.

Key Dates

Keywords

Hologic, HOLX, stock transaction, insider trading, Form 4, Benjamin Cohn, restricted stock units, tax obligations